Lack of Single-Use Standardization
Lack of Single-Use Standardization
Roche’s $50B US Boost: Jobs and Growth Ahead!
BIOT
Roche is investing $50B in U.S. manufacturing and R&D, creating jobs and addressing looming tariffs! 🇺🇸🏭📈 Biopharma Investment
Revolutionizing CGT Supply Chains for Patient Safety!
BIOT
Unlock the future of CGT! 🚀 Discover how TrakCel's Ocellos system standardizes supply chains, enhancing visibility, compliance, and patient safety. 📈🔄
Revolutionizing Therapy: Automation Slashes Production Costs!
BIOT
🌟 Discover how automation and standardization in cell and gene therapy can significantly lower production costs and improve accessibility! 💡✅🤝
Biopharma Struggles with Single-Use Standardization
BIOT
📰 Lack of Single-Use Standardization a Challenge for Biopharma: Industry struggles with flexibility, automation, and supplier dependency. 💊💼🔬
